Levinsky R J, Tiedeman K
Lancet. 1983 Mar 26;1(8326 Pt 1):671-2. doi: 10.1016/s0140-6736(83)91968-2.
A male infant with reticular dysgenesis received a bone-marrow transplant from his HLA-identical brother. Severe graft-versus-host disease developed but he responded to high-dose methylprednisolone. 3 years after grafting, the child is thriving with full haematological reconstitution and normal cell-mediated and humoral immunity. This is the first report of the survival beyond 17 weeks of a child with reticular dysgenesis.
一名患有网状发育不全的男婴接受了来自其 HLA 配型相同的哥哥的骨髓移植。出现了严重的移植物抗宿主病，但他对大剂量甲泼尼龙有反应。移植 3 年后，患儿茁壮成长，血液学完全重建，细胞介导免疫和体液免疫正常。这是网状发育不全患儿存活超过 17 周的首例报告。
